European Paediatric Cancer Community Proposal for Improvement of the EU Revised Pharmaceutical Legislation

European Paediatric Cancer Community Proposal for Improvement of the EU Revised Pharmaceutical Legislation On April 26th 2023, the European Commission released a proposal for revision of the Pharmaceutical legislation, which includes provisions on medicines for paediatric and rare diseases. Over the summer, CCI-E's and SIOPE's policy teams carried out an

Statement on the EU Pharmaceutical Proposal

Statement on the EU Pharmaceutical Proposal . The European Society for Paediatric Oncology (SIOP Europe), the single united European organisation representing healthcare professionals and researchers in paediatric oncology, and Childhood Cancer International – Europe (CCI Europe), the largest European patient organisation representing childhood cancer patients, parents and survivors, have been involved

The European Childhood Cancer Community Urgently Calls for the Release of the Proposal of the Revised EU Pharmaceutical legislation

. The European Childhood Cancer Community Urgently Calls for the Release of the Proposal of the Revised EU Pharmaceutical legislation The European Society for Paediatric Oncology (SIOP Europe), the single united European organisation representing healthcare professionals and researchers in paediatric oncology, and Childhood Cancer International – Europe (CCI Europe), the largest European

Understanding the EU Paediatric & Orphan Regulations – RECORDING AVAILABLE

Understanding the EU Paediatric & Orphan Regulations RECORDING AVAILABLE!On December 12, CCI Europe hosted the first of a series of educational webinars for its members and the paediatric oncology community. The challenging topic of understanding the EU Paediatric and Orphan Regulations was successfully presented by CCI Europe Committee Member & Lead

Revision of the EU paediatric and orphan Regulations: 6 key recommendations for Paediatric Cancers

Revision of the EU Paediatric and Orphan Regulations: 6 key recommendations for Paediatric Cancers  In the context of the EU’s Pharmaceutical Strategy, the EU Paediatric and Orphan Regulations are about to be reviewed and address shortcomings identified in a recent evaluation of the European Commission. Together with SIOP Europe, CCI

European Care Strategy

The European Childhood Cancer Community calls for bold implementation of the European Care Strategy On September 7th, 2022, the European Commission presented the European Care Strategy. This ambitious initiative aims at ensuring quality, affordable and accessible care services across Europe and improving the situation of care receivers and the

Go to Top